postpartum-hemorrhage

Documents about postpartum-hemorrhage

• Emotional and Cardiac Impact of Postpartum Haemorrhage#831320ClinicalTrials.gov
• The PPHgb Study: Non-Invasive Hemoglobin Measurement#862413ClinicalTrials.gov
• Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage#806216ClinicalTrials.gov
• The use of immersive technologies in learning about postpartum hemorrhage: Protocol for a systematic review and meta-analysis#292678PLOS
• The Effect Of Sımulatıon-Based Postpartum Bleedıng Management On Mıdwıfery Students#841804ClinicalTrials.gov
• Development and Validation of a Clinical Risk Score for Predicting Postpartum Hemorrhage in Women with Antepartum Hemorrhage.#152178NCBI PubMed Central
• Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women#850911ClinicalTrials.gov
• Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol#471528ClinicalTrials.gov
• Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial#912637ClinicalTrials.gov
• Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care#867321ClinicalTrials.gov
• Fertility After Intrauterine Tamponing Balloon: Where Are we#812448ClinicalTrials.gov
• Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section#845856ClinicalTrials.gov
• Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery#903201ClinicalTrials.gov
• Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections#874031ClinicalTrials.gov
• Standard Oxytocin Versus High Dose Oxytocin to Control Postpartum Hemorrhage in High Risk Pregnancy During Elective Cesarean Section#995012ClinicalTrials.gov
• A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery#900135ClinicalTrials.gov
• The Foley's Catheter Balloon to the Bleeding From Placenta Previa#908471ClinicalTrials.gov
• The Effect of Tranexamic Acid on Uterine Blood Flow After Vaginal Delivery#854233ClinicalTrials.gov
• WHO recommendations Uterotonics for the prevention of postpartum haemorrhage: Web annex 7: choice of uterotonic agents#413787WHO IRIS
• Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section#812830ClinicalTrials.gov
• Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections#856796ClinicalTrials.gov
• Tranexamic Acid in Patients for Caesarian Delivery.#1030503ClinicalTrials.gov
• WHO recommendations Uterotonics for the prevention of postpartum haemorrhage: Web annex 1: Oxytocin versus placebo or no treatment#413785WHO IRIS
• Estimating the incidence and risk factors of postpartum hemorrhage from the national ENACT network.#421278NCBI PubMed Central
• Oxytocin Versus, Sublingual Misoprostol in the Secondary Prevention of Postpartum Hemorrhage After Vaginal Delivery#804952ClinicalTrials.gov
• Prediction of Uterine Atony After Vaginal Delivery by Elastography#1030383ClinicalTrials.gov
• Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta#969403ClinicalTrials.gov
• Know Your Birth#397046Scholarly Commons
• Altered clot structure in pregnant women who will develop postpartum hemorrhage#685132HAL (France)
• Active Versus Expectant Management of the Third Stage of Labor#878141ClinicalTrials.gov
• Topical Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Women With Twin Pregnancy#893316ClinicalTrials.gov
• Hayman's Haemostatic Suture to Treat Severe Post-partum Haemorrhage#906539ClinicalTrials.gov
• Carbetocin at Elective Cesarean Delivery Part 4#916115ClinicalTrials.gov
• The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery#826568ClinicalTrials.gov
• Evaluating Postpartum Hemorrhage Transfusion Risk With a Machine Learning Model for Informed Consent: Retrospective Cohort Study.#318052NCBI PubMed Central
• Evidence summary of best practices for prevention and management of postpartum hemorrhage in obstetric clinical practice.#354576NCBI PubMed Central
• Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section#805284ClinicalTrials.gov
• Abdominal Ultrasound Assessment in the Post-cesarean Patient#841423ClinicalTrials.gov
• Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH#851320ClinicalTrials.gov
• Promptness of oxytocin administration for first-line treatment of postpartum hemorrhage: a national vignette-based study among midwives#430228HAL (France)
• Reduction of Adverse Pregnancy Outcomes With a Smartphone Application in Ghana#872231ClinicalTrials.gov
• Simulation for the Retention of Skills in the Management of Obstetric Hemorrhages#882484ClinicalTrials.gov
• Comparative satisfaction and effectiveness of virtual simulation and usual supervised work for postpartum hemorrhage management: a crossover randomized controlled trial#430236HAL (France)
• Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk.#878724ClinicalTrials.gov
• Routine Bilateral Uterine Artery Ligation During the Cesarean Delivery of Multiple Gestation#897911ClinicalTrials.gov
• Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge#803696ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers#908848ClinicalTrials.gov
• Mode of delivery for confirmed macrosomia: a real-life multicentric observational study#157626HAL (France)
• Timing of Umbilical Cord Clamping: One to Three Minutes vs. After Cessation of Cord Pulsation#879254ClinicalTrials.gov
• Tranexamic Acid Plus Buccal Misoprostol on Blood Loss During and After Cesarean Delivery#883082ClinicalTrials.gov